BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 7,820,000 Value ($000) $7,780 Avg Close — Range —
Q1 2024
Shares 7,975,000 Value ($000) $7,839 Avg Close — Range —
Q4 2023
Shares 8,704,000 Value ($000) $8,579 Avg Close — Range —
Q3 2023
Shares 8,704,000 Value ($000) $8,455 Avg Close — Range —
Q2 2023
Shares 9,478,000 Value ($000) $9,324 Avg Close — Range —
Q1 2023
Shares 10,093,000 Value ($000) $10,326 Avg Close — Range —
Q4 2022
Shares 10,733,000 Value ($000) $11,437 Avg Close — Range —
Q3 2022
Shares 12,475,000 Value ($000) $12,494 Avg Close — Range —
Q2 2022
Shares 10,703,000 Value ($000) $10,595 Avg Close — Range —
Q1 2022
Shares 14,548,000 Value ($000) $14,612 Avg Close — Range —
Q4 2021
Shares 11,686,000 Value ($000) $12,292 Avg Close — Range —
Q3 2021
Shares 10,836,000 Value ($000) $11,147 Avg Close — Range —
Q2 2021
Shares 3,000,000 Value ($000) $3,119 Avg Close — Range —
Q1 2021
Shares 3,000,000 Value ($000) $3,067 Avg Close — Range —
Q4 2020
Shares 3,000,000 Value ($000) $3,216 Avg Close — Range —
Q3 2020
Shares 2,000,000 Value ($000) $2,086 Avg Close — Range —
Q2 2020
Shares 2,000,000 Value ($000) $2,460 Avg Close — Range —